— Ticker · NYQ —
PFE · Pfizer Inc.
Healthcare · Drug Manufacturers - General
PFE
$25.85
▲ +0.39%
7-day move
7-day move
day$25.66 → $25.9052-wk$23.06 → $28.75avg vol37.6M / 3Mcap$147.3B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 9.1 |
| P/E (trailing) | 19.7 |
| EPS (forward) | $2.84 |
| EPS (trailing) | $1.31 |
| PEG | 13.77 |
| Dividend | 6.64% |
The Risk
| Beta | 0.30 |
| Short % float | 2.46% |
| Float | 5.69B |
| Shares out | 5.70B |
| Avg vol (3M) | 37.6M |
| 52w range | $23.06 → $28.75 |
The Analyst Tape
strong buybuyholdunderperformsell
$29.19
avg 12-mo target
+12.9%
vs. last · 27 analysts
At a Glance
$147.3B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryDrug Manufacturers - General
market cap$147.3B
websitepfizer.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for PFE in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for PFE.
Indicators That Mention PFE
2 of our 596 catalog map to PFE
SP-1190
Pfizer
Big pharma. Vaccine + small-molecule production via epa_pfe_waste.
49%
49%
50%
49%
49%
49%
●Still works on fresh data
r=-0.02
SP-3435
PFE TRI Chemical Releases
Annual chemical releases from Pfizer US plants. Pharma + vaccine production chemistry.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 297 indicators against four horizons. By chance alone, ~59 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust. This one too new to retest.Other Players in the Pipeline
Healthcare · by market cap · 7-day move